Meda N, Sangaré L, Lankoandé S, Sanou P T, Compaoré P I, Catraye J, Cartoux M, Soudré R B
Centre MURAZ, Organisation de Coordination et de Coopération pour la lutte contre les Grandes Endémies (OCCGE), Burkina Faso, West Africa.
Genitourin Med. 1997 Jun;73(3):188-93. doi: 10.1136/sti.73.3.188.
(1) To determine the prevalence of sexually transmitted diseases (STDs) in pregnant women in Burkina Faso. (2) To evaluate the potential of clinical management of STDs based on screening with clinical data and urine leucocyte esterase test (LET).
Cross sectional study among antenatal clinic attendees was conducted in 1994 in Ouagadougou and Bobo-Dioulasso, the two largest urban centres in Burkina Faso, where more than 94% of the pregnant women benefit from antenatal care at least twice during their pregnancy. Each woman selected underwent an interview, general and gynaecological examination. Genital samples were collected to confirm the presence of STD pathogens. Logistic regression analysis was done to identify models that predict (a) gonorrhoea and/or chlamydia, (b) trichomoniasis and/or bacterial vaginosis, (c) candidiasis. Sensitivity, specificity and positive and negative predictive values of these models were assessed using standard methods.
All 645 consecutive pregnant women were enrolled in the two sites. Among these women 32.4% presented at least one STD. The major STDs were: trichomoniasis (14%), bacterial vaginosis (13%), recent syphilis (3.6%), chlamydial infection (3.1%), genital warts (3%), gonococcal infection (1.6%) and genital ulcer (0.8%). Prevalence of vaginal candidiasis was 14%. The use of a risk marker (length of relationship with regular sexual partner < 3 years), and the positivity +3 of the urine LET provided a sensitivity of 80% and a positive predictive value of 7% for the screening of gonococcal and/or chlamydial infection. If clinical signs and positivity of the urine LET were taken into account sensitivity and positive predictive value of trichomoniasis and/or bacterial vaginosis screening were 77% and 37%, respectively. Clinical signs and positivity of the urine LET showed a low sensitivity (23%) for screening vaginal candidiasis.
The prevalence of STDs in pregnant women is high in urban Burkina Faso. Systematic screening combined with effective treatment should be included in antenatal care in the future. Urine LET, if associated with interview and clinical examination offers a simple, rapid and affordable tool for systematic screening of STDs in pregnant women. However, the proportion of overtreatments with proposed strategies will be high. Further studies are needed to develop and validate better algorithms with probably cheap laboratory tests.
(1)确定布基纳法索孕妇性传播疾病(STD)的患病率。(2)评估基于临床数据筛查和尿液白细胞酯酶试验(LET)进行性传播疾病临床管理的潜力。
1994年在布基纳法索两个最大的城市中心瓦加杜古和博博迪乌拉索对产前门诊就诊者进行了横断面研究,在那里超过94%的孕妇在孕期至少接受两次产前护理。每位入选的妇女都接受了访谈、全身及妇科检查。采集生殖器样本以确认性传播疾病病原体的存在。进行逻辑回归分析以确定预测(a)淋病和/或衣原体感染、(b)滴虫病和/或细菌性阴道病、(c)念珠菌病的模型。使用标准方法评估这些模型的敏感性、特异性以及阳性和阴性预测值。
两个研究地点共纳入645名连续的孕妇。在这些妇女中,32.4%至少患有一种性传播疾病。主要的性传播疾病有:滴虫病(14%)、细菌性阴道病(13%)、近期梅毒(3.6%)、衣原体感染(3.1%)、尖锐湿疣(3%)、淋球菌感染(1.6%)和生殖器溃疡(0.8%)。阴道念珠菌病的患病率为14%。使用一个风险标志物(与固定性伴侣的关系时长<3年)以及尿液LET呈阳性+3,对淋病和/或衣原体感染筛查的敏感性为80%,阳性预测值为7%。如果考虑临床体征和尿液LET呈阳性,则滴虫病和/或细菌性阴道病筛查的敏感性和阳性预测值分别为77%和37%。临床体征和尿液LET呈阳性对阴道念珠菌病筛查的敏感性较低(23%)。
布基纳法索城市地区孕妇性传播疾病的患病率很高。未来产前护理应纳入系统筛查并结合有效治疗。尿液LET如果与访谈和临床检查相结合,为孕妇性传播疾病的系统筛查提供了一种简单、快速且经济实惠的工具。然而,采用所提议策略进行过度治疗的比例会很高。需要进一步研究以开发和验证可能结合廉价实验室检测的更好算法。